330728P

C13 Galactosyl(β) Ceramide-d7 (d18:1-D7/13:0)

Avanti Research^™ - A Croda Brand

• Synonym(e): D-galactosyl-β-1,1′-N-tridecanoyl-D-erythro-sphingosine-d7
• Empirische Formel (Hill-System): C₃₇H₆₄D₇NO₈
• CAS-Nummer: 2315262-19-0
• Molekulargewicht: 665.00
• UNSPSC-Code: 12352211
• NACRES: NA.12

Eigenschaften

• Assay: 99% (TLC)
• Form: powder
• Verpackung: pkg of 1 × 1 mg (330728P-1MG)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [H][C@](/C=C/CCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])(O)[C@@]([H])(NC(CCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H](O)[C@H]1CO

Beschreibung

Allgemeine Beschreibung

C13 Galactosyl(β) Ceramide-d7 (d18:1-D7/13:0) is deuterated derivative of C13 Galactosyl(β) Ceramide. β-Galactosyl ceramide (β −GalCer) is one of the uncomplicated glycosphingolipid. It contains a lipophilic sphingosine and a hydrophilic galactose moiety, which is attached to sphingosine via an ether linkage. It is localized in the myelin sheath of the peripheral and central nervous system.

Biochem./physiol. Wirkung

β-Galactosyl ceramide (β −GalCer) plays a role in regulating the activity of β-glucocerebrosidase (β-GlcCer′ase). It is also a receptor for various bacterial and viral toxins.

Verpackung

5 mL Amber Glass Screw Cap Vial

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable